| # | Drug | Count |
|---|---|---|
| 0 | APIXABAN | 133 |
| 1 | RIVAROXABAN | 116 |
| 2 | ASPIRIN | 91 |
| 3 | ASPIRIN 325 MG | 86 |
| 4 | ASPIRIN 81 MG | 86 |
| 5 | DABIGATRAN ETEXILATE MESYLATE | 71 |
| 6 | CLOPIDOGREL | 60 |
| 7 | DABIGATRAN ETEXILATE | 57 |
| 8 | FUROSEMIDE | 53 |
| 9 | BISOPROLOL FUMARATE | 44 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IDARUCIZUMAB | 3 | 0.0021 |
| 1 | APIXABAN | 133 | 0.0020 |
| 2 | DABIGATRAN ETEXILATE MESYLATE | 71 | 0.0010 |
| 3 | SOTATERCEPT-CSRK | 6 | 0.0010 |
| 4 | ERGOCALCIFEROL | 26 | 0.0009 |
| 5 | RASAGILINE MESYLATE | 9 | 0.0008 |
| 6 | KETAMINE HYDROCHLORIDE | 4 | 0.0008 |
| 7 | EMICIZUMAB | 10 | 0.0008 |
| 8 | DABIGATRAN ETEXILATE | 57 | 0.0007 |
| 9 | MANNITOL | 3 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Factor Xa Inhibitor [EPC] | 248 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 116 |
| 2 | Platelet Aggregation Inhibitor [EPC] | 92 |
| 3 | Loop Diuretic [EPC] | 60 |
| 4 | Corticosteroid [EPC] | 48 |
| 5 | beta-Adrenergic Blocker [EPC] | 40 |
| 6 | Kinase Inhibitor [EPC] | 38 |
| 7 | Proton Pump Inhibitor [EPC] | 37 |
| 8 | P2Y12 Platelet Inhibitor [EPC] | 36 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 29 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Humanized Monoclonal Antibody Fragment [EPC] | 3 | 0.0021 |
| 1 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 2 | 0.0013 |
| 2 | Factor Xa Inhibitor [EPC] | 248 | 0.0009 |
| 3 | Provitamin D2 Compound [EPC] | 26 | 0.0009 |
| 4 | Osmotic Diuretic [EPC] | 3 | 0.0006 |
| 5 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 6 | Amyloid Beta-directed Antibody [EPC] | 2 | 0.0005 |
| 7 | Autologous Cellular Immunotherapy [EPC] | 3 | 0.0005 |
| 8 | Neonatal Fc Receptor Blocker [EPC] | 2 | 0.0005 |
| 9 | CCR5 Co-receptor Antagonist [EPC] | 1 | 0.0004 |